Five cups of coffee daily may halve liver cancer risk: study

Decaffeinated coffee also found to have a beneficial, though less marked effect, says research

Image via Shutterstock
<a href="http://www.shutterstock.com/pic-116790940.html" target="_blank">Image</a> via Shutterstock
Press Trust of India London
Last Updated : May 29 2017 | 7:58 PM IST
Drinking about five cups of coffee every day may halve the risk of developing the most common form of liver cancer, new research has claimed.

Researchers from the University of Southampton and the University of Edinburgh in the UK found that the more coffee consumed the greater the protection against hepatocellular cancer (HCC).

Drinking one cup more of caffeinated coffee a day was associated with a 20 per cent reduction in the risk of developing HCC, two cups more with a 35 per cent reduction, and up to five cups with a halving of the risk.

Also Read

The protection was found to be the same for both existing coffee-drinkers and those who did not usually drink it, and the more coffee consumed the greater the effect - although there was little data available above five cups a day.

Decaffeinated coffee was also found to have a beneficial, though less marked, effect, researchers said.

The study, published in the journal BMJ Open, examined the data from 26 observational studies, involving more than 2.25 million participants, to calculate the relative risks of developing HCC for drinking between one and five cups of caffeinated coffee a day.

"Coffee is widely believed to possess a range of health benefits, and these latest findings suggest it could have a significant effect on liver cancer risk," said Oliver Kennedy, from the University of Southampton.

"Our findings are an important development given the increasing evidence of HCC globally and its poor prognosis," said Kennedy.

HCC is the second leading cause of cancer death globally due to its poor prognosis and high frequency, especially in China and Southeast Asia. It mostly develops in people who are already suffering from a chronic liver disease.

It is estimated that, by 2030, the number of new cases annually will have risen by about 50 per cent to more than 1.2 million.

The compound molecules found in coffee possess antioxidant, anti-inflammatory, anticarcinogenic and other beneficial properties which scientists believe may explain the lower rates of chronic liver disease and liver cancer experienced by coffee-drinkers, researchers said.

About 2.25 billion cups of coffee are consumed daily worldwide, and increased coffee consumption has already been shown to protect against serious non-cancer chronic liver disease (cirrhosis).

"We have shown that coffee reduces cirrhosis and also liver cancer in a dose-dependent manner. Coffee has also been reported to reduce the risk of death from many other causes," said Peter Hayes, from the University of Edinburgh.

"Our research adds to the evidence that, in moderation, coffee can be a wonderful natural medicine," said Hayes.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 29 2017 | 7:58 PM IST

Next Story